Join
Live feed
·
NEWSReleasevia Quantisnow
Sunshine Biopharma Inc. logo

Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market

ByQuantisnow·Wall Street's wire, on your screen.
SBFM· Sunshine Biopharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SBFM (Sunshine Biopharma Inc.) and more on Quantisnow.